Interstitial Lung Disease
Interstitial lung disease (ILD) is a term used to describe a diverse group of disorders found in the tissue between the air sacs of the lungs that lead to fibrosis or scarring of the interstitial tissue. Scarring or inflammation of the interstitial tissue makes it difficult for oxygen to reach the lungs. Interstitial lung disease usually begins with coughing or shortness of breath and results in more severe symptoms. A wide range of disorders can be associated with a systemic disease or have an unknown cause. Interstitial lung disease is often difficult to diagnose and requires several tests and approaches. There are over 100 diseases classified as ILD, so an accurate diagnosis is vital to provide more information and treatment options.
Related Conference of Interstitial Lung Disease
15th International Conference on Pulmonary & Respiratory Medicine
4th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
Interstitial Lung Disease Conference Speakers
Recommended Sessions
- Airway and Therapeutic Devices
- Asthma and Allergy
- Cardiopulmonary Disorders
- Case Reports in Pulmonology
- Chronic Bronchitis and Respiratory Diseases
- Chronic Obstructive Pulmonary Disease
- Cystic Fibrosis
- Idiopathic Pulmonary Fibrosis
- Interstitial Lung Disease
- Lung Diseases
- Obstructive sleep apnea
- Pediatric Pulmonology and Critical care
- Pulmonary Diseases and therapeutics
- Pulmonary Hypertension
- Pulmonary Rehabilitation
- Respiratory tract Infections
- Sarcoidosis
- Thoracic
- Tuberculosis
Related Journals
Are you interested in
- Advancements in Pulmonary Diagnostics - Respiratory 2024 (France)
- Asthma - Tuberculosis-2024 (France)
- Atelectasis and Pneumothorax - Tuberculosis-2024 (France)
- Cardio Pulmonary Disorders - Respiratory 2024 (France)
- Cardiopulmonary Disease - Tuberculosis-2024 (France)
- Chronic Obstructive Pulmonary Disease - Respiratory 2024 (France)
- Chronic Obstructive Pulmonary Disease (COPD) - Tuberculosis-2024 (France)
- Climate Change and Respiratory Diseases - Tuberculosis-2024 (France)
- COVID-19 and Asthma - Respiratory 2024 (France)
- COVID-19 and Respiratory System - Respiratory 2024 (France)
- Epidemiology of TB Disease - Tuberculosis-2024 (France)
- Gastroesophageal reflux disease (GERD) - Tuberculosis-2024 (France)
- Idiopathic Pulmonary Fibrosis - Respiratory 2024 (France)
- Interstitial Lung Disease - Respiratory 2024 (France)
- Latent TB Infection and Active TB Disease - Tuberculosis-2024 (France)
- Lung Cancer - Respiratory 2024 (France)
- Lung Cancer: Screening, Diagnosis & Treatment - Tuberculosis-2024 (France)
- Lung Function in Men with and without HIV - Tuberculosis-2024 (France)
- Lung Infection - Tuberculosis-2024 (France)
- Lung Transplantation - Respiratory 2024 (France)
- Multidrug-resistant TB - Tuberculosis-2024 (France)
- Mycobacterial Infections - Tuberculosis-2024 (France)
- Obstructive Sleep Apnea - Respiratory 2024 (France)
- Occupational Lung Diseases - Respiratory 2024 (France)
- Palliative Care for Advanced Lung Cancer - Tuberculosis-2024 (France)
- Pneumonia - Respiratory 2024 (France)
- Pulmonary Complications of Endocrine Diseases - Tuberculosis-2024 (France)
- Pulmonary Diseases and Therapeutics - Tuberculosis-2024 (France)
- Pulmonary diseases: Treatment, Diagnosis and therapies - Respiratory 2024 (France)
- Pulmonary Edema - Tuberculosis-2024 (France)
- Pulmonary Hypertension - Respiratory 2024 (France)
- Pulmonary Rehabilitation - Respiratory 2024 (France)
- TB Clinical Trials - Tuberculosis-2024 (France)
- TB Diagnosis, Prevention & Treatment - Tuberculosis-2024 (France)
- TB Vaccines - Tuberculosis-2024 (France)
- TB-HIV Co-infections - Tuberculosis-2024 (France)
- Tuberculosis - Respiratory 2024 (France)
- Zoonotic TB - Tuberculosis-2024 (France)